These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 32117713)

  • 61. Distinct hepatitis B virus integration patterns in hepatocellular carcinoma and adjacent normal liver tissue.
    Yang X; Wu L; Lin J; Wang A; Wan X; Wu Y; Robson SC; Sang X; Zhao H
    Int J Cancer; 2017 Mar; 140(6):1324-1330. PubMed ID: 27943263
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Long non-coding RNA HOTTIP is frequently up-regulated in hepatocellular carcinoma and is targeted by tumour suppressive miR-125b.
    Tsang FH; Au SL; Wei L; Fan DN; Lee JM; Wong CC; Ng IO; Wong CM
    Liver Int; 2015 May; 35(5):1597-606. PubMed ID: 25424744
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Reconstruction and Analysis of the Differentially Expressed IncRNA-miRNA-mRNA Network Based on Competitive Endogenous RNA in Hepatocellular Carcinoma.
    Cao D; Wang Y; Li D; Wang L
    Crit Rev Eukaryot Gene Expr; 2019; 29(6):539-549. PubMed ID: 32422009
    [TBL] [Abstract][Full Text] [Related]  

  • 64. WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1.
    Chen Y; Peng C; Chen J; Chen D; Yang B; He B; Hu W; Zhang Y; Liu H; Dai L; Xie H; Zhou L; Wu J; Zheng S
    Mol Cancer; 2019 Aug; 18(1):127. PubMed ID: 31438961
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Identifying Differentially Expressed MicroRNAs Between Cirrhotic and Non-Cirrhotic Hepatocellular Carcinoma and Exploring Their Functions Using Bioinformatic Analysis.
    Mei Y; You Y; Xia J; Gong JP; Wang YB
    Cell Physiol Biochem; 2018; 48(4):1443-1456. PubMed ID: 30064138
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Genome-wide identification and characterization of tissue-specific RNA editing events in D. melanogaster and their potential role in regulating alternative splicing.
    Mazloomian A; Meyer IM
    RNA Biol; 2015; 12(12):1391-401. PubMed ID: 26512413
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Targeted genomic profiling identifies frequent deleterious mutations in FAT4 and TP53 genes in HBV-associated hepatocellular carcinoma.
    Huang FY; Wong DK; Tsui VW; Seto WK; Mak LY; Cheung TT; Lai KK; Yuen MF
    BMC Cancer; 2019 Aug; 19(1):789. PubMed ID: 31395065
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Invasion and metastasis-related long noncoding RNA expression profiles in hepatocellular carcinoma.
    Gao Y; Chen G; Zeng Y; Zeng J; Lin M; Liu X; Liu J
    Tumour Biol; 2015 Sep; 36(10):7409-22. PubMed ID: 25900874
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Characterization of Hepatocellular Carcinoma Cell Lines Using a Fractionation-Then-Sequencing Approach Reveals Nuclear-Enriched HCC-Associated lncRNAs.
    Chow EY; Zhang J; Qin H; Chan TF
    Front Genet; 2019; 10():1081. PubMed ID: 31781161
    [No Abstract]   [Full Text] [Related]  

  • 70. Low expression of miR-199 in hepatocellular carcinoma contributes to tumor cell hyper-proliferation by negatively suppressing XBP1.
    Lou Z; Gong YQ; Zhou X; Hu GH
    Oncol Lett; 2018 Nov; 16(5):6531-6539. PubMed ID: 30405792
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Upregulation of ubiquitin-conjugating enzyme E2Z is associated with human hepatocellular carcinoma.
    Shi X; Wang B; Chen X; Zheng Y; Ding Y; Wang C
    Biochem Biophys Res Commun; 2020 Feb; 523(1):25-32. PubMed ID: 31831168
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Uncovering RNA Editing Sites in Long Non-Coding RNAs.
    Picardi E; D'Erchia AM; Gallo A; Montalvo A; Pesole G
    Front Bioeng Biotechnol; 2014; 2():64. PubMed ID: 25538940
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Integrating subpathway analysis to identify candidate agents for hepatocellular carcinoma.
    Wang J; Li M; Wang Y; Liu X
    Onco Targets Ther; 2016; 9():1221-30. PubMed ID: 27022281
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Dynamic Editome of Zebrafish under Aminoglycosides Treatment and Its Potential Involvement in Ototoxicity.
    Yan S; Lu Y; He L; Zhao X; Wu L; Zhu H; Jiang M; Su Y; Cao W; Tian W; Xing Q
    Front Pharmacol; 2017; 8():854. PubMed ID: 29213239
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Human Brain Shows Recurrent Non-Canonical MicroRNA Editing Events Enriched for Seed Sequence with Possible Functional Consequence.
    Paul D; Ansari AH; Lal M; Mukhopadhyay A
    Noncoding RNA; 2020 Jun; 6(2):. PubMed ID: 32498345
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Genome-wide characterization of RNA editing highlights roles of high editing events of glutamatergic synapse during mouse retinal development.
    Li C; Shi X; Yang J; Li K; Dai L; Zhang Y; Zhou M; Su J
    Comput Struct Biotechnol J; 2022; 20():2648-2656. PubMed ID: 35685368
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Widespread RNA hypoediting in schizophrenia and its relevance to mitochondrial function.
    Choudhury M; Fu T; Amoah K; Jun HI; Chan TW; Park S; Walker DW; Bahn JH; Xiao X
    Sci Adv; 2023 Apr; 9(14):eade9997. PubMed ID: 37027465
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Global characterization of RNA editing in genetic regulation of multiple ovarian cancer subtypes.
    Wang Y; Wu J; Zhao J; Xu T; Zhang M; Liu J; Wang Y; Wang Q; Song X
    Mol Ther Nucleic Acids; 2024 Mar; 35(1):102127. PubMed ID: 38352860
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Clinical Relevance of RNA Editing to Early Detection of Cancer in Human.
    Ullah M; Akbar A
    Int J Stem Cell Res Ther; 2020; 7(1):. PubMed ID: 33215051
    [TBL] [Abstract][Full Text] [Related]  

  • 80. RNA editing in cancer: Mechanistic, prognostic, and therapeutic implications.
    Han L; Liang H
    Mol Cell Oncol; 2016 Mar; 3(2):e1117702. PubMed ID: 27308619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.